Takeda Pharmaceutical
TAK
#418
Rank
NZ$99.14 B
Marketcap
NZ$31.38
Share price
0.65%
Change (1 day)
33.23%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): NZ$5.55 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.86 Billion. , an increase over its 2024 earnings that were of NZ$3.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 NZ$5.59 B49.03%
2024 NZ$3.75 B-2.41%
2023 NZ$3.84 B-28.14%
2022 NZ$5.35 B-40.9%
2021 NZ$9.05 B78.24%
2020 NZ$5.08 B246.1%
2019 NZ$1.46 B-48.79%
2018 NZ$2.86 B-23.64%
2017 NZ$3.75 B21.7%
2016 NZ$3.08 B-253.01%
2015 -NZ$2.02 Billion-159.65%
2014 NZ$3.37 B13%
2013 NZ$2.99 B2.46%
2012 NZ$2.91 B-57.05%
2011 NZ$6.79 B-10.49%
2010 NZ$7.59 B-3.99%
2009 NZ$7.90 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.48 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.50 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.93 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.86 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.30 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$38.83 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.68 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.33 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.46 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India